Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials. Chen W, Reddel HK, FitzGerald JM, Beasley R, et al. Respir Res 2023;24:120.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen W, Reddel HK, FitzGerald JM, Beasley R, et al. Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials. Respir Res 2023;24:120.
PMID: 37131185